The treatment of Canavan disease is aimed at alleviating the problems associated with the disease. Seats with full support for the head are used, liquid diets or feeding tubes may be used since swallowing may become difficult, and medications to control or reduce seizures and irritability may be administered.

Recently, an experimental gene therapy project began for Canavan disease. This study intends to transfer an unchanged copy of the gene to the brain cells of a patient. This gene transfer has the potential to increase the amount of ASPA in the brain and thus allow breakdown of NAA.

Our medical team provides comprehensive, compassionate care and maintains long-lasting relationships with our patients, their families, and their physicians to address all issues of concern. We are committed to offering the latest diagnostic testing, treatments, and therapies to our patients.